Local Novartis websites
Novartis Businesses
Other Novartis websites
General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

The Malaria Initiative

Treatment

For over a decade, Novartis has been in the front ranks of a change in the treatment of malaria – by launching a new generation antimalarial medicine known as artemisinin-based combination therapy, or ACT. »

Access

The Novartis Malaria Initiative has pioneered the healthcare response to the fight against malaria by spearheading what has become one of the industry’s largest access-to-medicine programs today. »

Capacity building

Building capacity on the ground is important to increase access to medicines in developing countries by bringing together training in good clinical practice, logistics management and other types of expertise. »

Research & Development

At Novartis, we leverage both the expertise of our large research family and our unique network of external partners to research and develop best-in-class compounds against malaria. »

Top links
Top downloads

Children's corner ›
Leo & Kya are friends against malaria. Access our interactive toolkit and educate your children about malaria.